Literature DB >> 1827052

The current status of edrophonium: have we come "full circle"?

A F Kopman.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1827052     DOI： 10.1007/BF03008134

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN： 0832-610X            Impact factor:   5.063


× No keyword cloud information.
  26 in total

1.  THE D-TUBOCURARINE DILEMMA.

Authors:  H C CHURCHILL-DAVIDSON
Journal:  Anesthesiology       Date:  1965 Mar-Apr       Impact factor: 7.892

2.  Reversal of profound paralysis: use of large doses of edrophonium to antagonize vecuronium and pancuronium induced neuromuscular blockade.

Authors:  S J Power; R M Jones
Journal:  Acta Anaesthesiol Scand       Date:  1989-08       Impact factor: 2.105

Review 3.  Antagonism of neuromuscular blockade.

Authors:  R D Miller
Journal:  Anesthesiology       Date:  1976-04       Impact factor: 7.892

4.  Tactile and visual evaluation of the response to train-of-four nerve stimulation.

Authors:  J Viby-Mogensen; N H Jensen; J Engbaek; H Ording; L T Skovgaard; B Chraemmer-Jørgensen
Journal:  Anesthesiology       Date:  1985-10       Impact factor: 7.892

5.  Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium.

Authors:  J Engbaek; H Ording; D Ostergaard; J Viby-Mogensen
Journal:  Acta Anaesthesiol Scand       Date:  1985-07       Impact factor: 2.105

6.  Edrophonium antagonism of pancuronium-induced neuromuscular blockade in man: a reappraisal.

Authors:  A F Kopman
Journal:  Anesthesiology       Date:  1979-08       Impact factor: 7.892

7.  Neostigmine, pyridostigmine and edrophonium as antagonists of deep pancuronium blockade.

Authors:  F Donati; J Lahoud; D McCready; D R Bevan
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

8.  Antagonism of vecuronium-induced neuromuscular blockade with edrophonium or neostigmine.

Authors:  R K Mirakhur; F M Gibson; G G Lavery
Journal:  Br J Anaesth       Date:  1987-04       Impact factor: 9.166

9.  Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade.

Authors:  M Abdulatif; M Naguib
Journal:  Can J Anaesth       Date:  1991-03       Impact factor: 5.063

10.  Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia.

Authors:  R Cronnelly; R B Morris; R D Miller
Journal:  Anesthesiology       Date:  1982-10       Impact factor: 7.892
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.